AI algorithm accurately IDs two life-threatening heart conditions
Mar 14, 2022
The model can distinguish between hypertrophic cardiomyopathy and cardiac amyloidosis using ultrasound videos.
Oral probenecid cuts time to viral clearance in COVID-19
Aug 01, 2023
The median time to viral clearance was significantly shorter for 500 and 1,000 mg probenecid versus placebo.
FDA approves new diet drug Zepbound, a version of the diabetes med Mounjaro
Nov 09, 2023
Zepbound works by activating hormone receptors in the body to reduce appetite and food intake
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.
CDC signs off on Moderna, J&J boosters, backs mix ‘n’ match shots
Oct 22, 2021
The agency plans to release guidance early next week about who might benefit from choosing one booster over another.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
First FDA-approved fecal-based treatment helps fight C. difficile
Dec 01, 2022
Rebyota is prepared from human stool donated by qualified individuals.
FDA approves first RSV vaccine
May 03, 2023
Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.
FDA approval of new COVID-19 boosters could come by Friday
Sep 07, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.